Skip to main navigation Skip to search Skip to main content

Defining the phenotypic spectrum of SLC6A1 mutations

  • Katrine M. Johannesen
  • , Elena Gardella*
  • , Tarja Linnankivi
  • , Carolina Courage
  • , Anne de Saint Martin
  • , Anna Elina Lehesjoki
  • , Cyril Mignot
  • , Alexandra Afenjar
  • , Gaetan Lesca
  • , Marie Thérèse Abi-Warde
  • , Jamel Chelly
  • , Amélie Piton
  • , J. Lawrence Merritt
  • , Lance H. Rodan
  • , Wen Hann Tan
  • , Lynne M. Bird
  • , Mark Nespeca
  • , Joseph G. Gleeson
  • , Yongjin Yoo
  • , Murim Choi
  • Jong Hee Chae, Desiree Czapansky-Beilman, Sara Chadwick Reichert, Manuela Pendziwiat, Judith S. Verhoeven, Helenius J. Schelhaas, Orrin Devinsky, Jakob Christensen, Nicola Specchio, Marina Trivisano, Yvonne G. Weber, Caroline Nava, Boris Keren, Diane Doummar, Elise Schaefer, Sarah Hopkins, Holly Dubbs, Jessica E. Shaw, Laura Pisani, Candace T. Myers, Sha Tang, Shan Tang, Deb K. Pal, John J. Millichap, Gemma L. Carvill, Kathrine L. Helbig, Oriano Mecarelli, Pasquale Striano, Guido Rubboli, Rikke S. Møller
*Corresponding author for this work
  • Children's Hospital Helsinki
  • University of Helsinki
  • Molecular Neurology and Neuroscience Center
  • University Hospitals of Strasbourg
  • Reference Center for Rare Epilepsies
  • Pierre and Marie Curie University
  • Armand-Trousseau Children's Hospital
  • University of Lyon
  • Institut de Chimie et Biochimie Moléculaire et Supramoléculaire
  • French National Institute of Health
  • IGBMC Institut de Genetique et de Biologie Moleculaire et Cellulaire
  • University of Washington
  • Boston Children's Hospital
  • Harvard Medical School
  • University of California
  • Seoul National University
  • Seoul National University Hospital
  • Gillette Children's Specialty Healthcare
  • Children's Minnesota
  • Campus Kiel
  • Academic Center for Epileptology
  • New York University
  • Bambino Gesù Children’s Hospital
  • Eberhard Karls University of Tübingen
  • Public Hospital System of Paris
  • Universite Paris Sorbonne - Paris IV
  • Children's Hospital of Philadelphia
  • Columbia University Medical Center
  • Division of Clinical Genomics
  • King's College London
  • Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Northwestern University Feinberg School of Medicine
  • Sapienza University of Rome
  • University of Genoa
  • Aarhus University Hospital
  • University of Copenhagen

Research output: Contribution to journal › Journal article › Research › peer-review

406 Downloads (Pure)

Abstract

Objective: Pathogenic SLC6A1 variants were recently described in patients with myoclonic atonic epilepsy (MAE) and intellectual disability (ID). We set out to define the phenotypic spectrum in a larger cohort of SCL6A1-mutated patients. Methods: We collected 24 SLC6A1 probands and 6 affected family members. Four previously published cases were included for further electroclinical description. In total, we reviewed the electroclinical data of 34 subjects. Results: Cognitive development was impaired in 33/34 (97%) subjects; 28/34 had mild to moderate ID, with language impairment being the most common feature. Epilepsy was diagnosed in 31/34 cases with mean onset at 3.7 years. Cognitive assessment before epilepsy onset was available in 24/31 subjects and was normal in 25% (6/24), and consistent with mild ID in 46% (11/24) or moderate ID in 17% (4/24). Two patients had speech delay only, and 1 had severe ID. After epilepsy onset, cognition deteriorated in 46% (11/24) of cases. The most common seizure types were absence, myoclonic, and atonic seizures. Sixteen cases fulfilled the diagnostic criteria for MAE. Seven further patients had different forms of generalized epilepsy and 2 had focal epilepsy. Twenty of 31 patients became seizure-free, with valproic acid being the most effective drug. There was no clear-cut correlation between seizure control and cognitive outcome. Electroencephalography (EEG) findings were available in 27/31 patients showing irregular bursts of diffuse 2.5-3.5 Hz spikes/polyspikes-and-slow waves in 25/31. Two patients developed an EEG pattern resembling electrical status epilepticus during sleep. Ataxia was observed in 7/34 cases. We describe 7 truncating and 18 missense variants, including 4 recurrent variants (Gly232Val, Ala288Val, Val342Met, and Gly362Arg). Significance: Most patients carrying pathogenic SLC6A1 variants have an MAE phenotype with language delay and mild/moderate ID before epilepsy onset. However, ID alone or associated with focal epilepsy can also be observed.

Original languageEnglish
JournalEpilepsia
Volume59
Issue number2
Pages (from-to)389-402
ISSN0013-9580
DOIs
Publication statusPublished - 2018

Keywords

  • epilepsy
  • epilepsy genetics
  • MAE
  • SLC6A1

Fingerprint

Dive into the research topics of 'Defining the phenotypic spectrum of SLC6A1 mutations'. Together they form a unique fingerprint.

Cite this